Does the media refer more to CNMD or MMSI?

In the previous week, Merit Medical Systems had 1 more articles in the media than CONMED. MarketBeat recorded 5 mentions for Merit Medical Systems and 4 mentions for CONMED. Merit Medical Systems' average media sentiment score of 1.02 beat CONMED's score of 0.20 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, LIVN or CNMD?

CONMED has lower revenue, but higher earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivaNova $1.39B 2.96 -$242.47M $1.95 38.36 CONMED $1.37B 0.76 $47.06M $1.77 19.51

Is LIVN or CNMD more profitable?

LivaNova has a net margin of 7.48% compared to CONMED's net margin of 4.00%. LivaNova's return on equity of 16.48% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets LivaNova 7.48% 16.48% 7.59% CONMED 4.00% 13.84% 6.05%

Does the media prefer LIVN or CNMD?

In the previous week, LivaNova and LivaNova both had 4 articles in the media. CONMED's average media sentiment score of 0.20 beat LivaNova's score of 0.06 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CONMED 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CNMD or NVST more profitable?

CONMED has a net margin of 4.00% compared to Envista's net margin of 2.41%. CONMED's return on equity of 13.84% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.00% 13.84% 6.05% Envista 2.41% 7.11% 3.91%

Does the media prefer CNMD or NVST?

In the previous week, CONMED had 3 more articles in the media than Envista. MarketBeat recorded 4 mentions for CONMED and 1 mentions for Envista. Envista's average media sentiment score of 0.50 beat CONMED's score of 0.20 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or CNMD?

In the previous week, iRhythm Technologies and iRhythm Technologies both had 4 articles in the media. iRhythm Technologies' average media sentiment score of 1.35 beat CONMED's score of 0.20 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, CNMD or MMED?

CONMED has higher earnings, but lower revenue than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 0.76 $47.06M $1.77 19.51 MiniMed Group $2.99B 1.40 N/A N/A N/A

Does the media prefer CNMD or MMED?

In the previous week, MiniMed Group had 5 more articles in the media than CONMED. MarketBeat recorded 9 mentions for MiniMed Group and 4 mentions for CONMED. CONMED's average media sentiment score of 0.20 beat MiniMed Group's score of -0.23 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

CONMED (CNMD) Competitors

$34.54 -0.62 (-1.77%)

Closing price 03:59 PM Eastern

Extended Trading

$34.49 -0.05 (-0.14%)

As of 07:20 PM Eastern

Compare

CNMD vs. MMSI, LIVN, NVST, IRTC, and MMED

Should you buy CONMED stock or one of its competitors? MarketBeat compares CONMED with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CONMED include Merit Medical Systems (MMSI), LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), and MiniMed Group (MMED).

How does CONMED compare to Merit Medical Systems?

CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment.

CONMED currently has a consensus target price of $43.80, suggesting a potential upside of 26.81%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 40.54%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

99.7% of Merit Medical Systems shares are held by institutional investors. 0.3% of CONMED shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Merit Medical Systems has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.76	$47.06M	$1.77	19.51
Merit Medical Systems	$1.52B	2.60	$128.49M	$2.31	28.58

Merit Medical Systems has a net margin of 9.03% compared to CONMED's net margin of 4.00%. CONMED's return on equity of 13.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
Merit Medical Systems	9.03%	13.54%	7.94%

In the previous week, Merit Medical Systems had 1 more articles in the media than CONMED. MarketBeat recorded 5 mentions for Merit Medical Systems and 4 mentions for CONMED. Merit Medical Systems' average media sentiment score of 1.02 beat CONMED's score of 0.20 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market.

Summary

Merit Medical Systems beats CONMED on 14 of the 16 factors compared between the two stocks.

How does CONMED compare to LivaNova?

LivaNova (NASDAQ:LIVN) and CONMED (NYSE:CNMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

LivaNova presently has a consensus price target of $79.38, indicating a potential upside of 6.12%. CONMED has a consensus price target of $43.80, indicating a potential upside of 26.81%. Given CONMED's higher possible upside, analysts clearly believe CONMED is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

97.6% of LivaNova shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, LivaNova and LivaNova both had 4 articles in the media. CONMED's average media sentiment score of 0.20 beat LivaNova's score of 0.06 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LivaNova has a net margin of 7.48% compared to CONMED's net margin of 4.00%. LivaNova's return on equity of 16.48% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
CONMED	4.00%	13.84%	6.05%

CONMED has lower revenue, but higher earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	2.96	-$242.47M	$1.95	38.36
CONMED	$1.37B	0.76	$47.06M	$1.77	19.51

LivaNova has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, CONMED has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

Summary

LivaNova beats CONMED on 11 of the 15 factors compared between the two stocks.

How does CONMED compare to Envista?

CONMED (NYSE:CNMD) and Envista (NYSE:NVST) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

CONMED has a net margin of 4.00% compared to Envista's net margin of 2.41%. CONMED's return on equity of 13.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
Envista	2.41%	7.11%	3.91%

CONMED has higher earnings, but lower revenue than Envista. CONMED is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.76	$47.06M	$1.77	19.51
Envista	$2.72B	1.40	$47M	$0.41	57.20

CONMED has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, Envista has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

CONMED presently has a consensus price target of $43.80, indicating a potential upside of 26.81%. Envista has a consensus price target of $28.83, indicating a potential upside of 22.94%. Given CONMED's higher possible upside, analysts plainly believe CONMED is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, CONMED had 3 more articles in the media than Envista. MarketBeat recorded 4 mentions for CONMED and 1 mentions for Envista. Envista's average media sentiment score of 0.50 beat CONMED's score of 0.20 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CONMED beats Envista on 8 of the 14 factors compared between the two stocks.

How does CONMED compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and CONMED (NYSE:CNMD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

In the previous week, iRhythm Technologies and iRhythm Technologies both had 4 articles in the media. iRhythm Technologies' average media sentiment score of 1.35 beat CONMED's score of 0.20 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED has a net margin of 4.00% compared to iRhythm Technologies' net margin of -3.53%. CONMED's return on equity of 13.84% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
CONMED	4.00%	13.84%	6.05%

CONMED has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.72	-$44.55M	-$0.86	N/A
CONMED	$1.37B	0.76	$47.06M	$1.77	19.51

iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, CONMED has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

iRhythm Technologies presently has a consensus price target of $189.69, suggesting a potential upside of 76.90%. CONMED has a consensus price target of $43.80, suggesting a potential upside of 26.81%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe iRhythm Technologies is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

iRhythm Technologies and CONMED tied by winning 7 of the 14 factors compared between the two stocks.

How does CONMED compare to MiniMed Group?

CONMED (NYSE:CNMD) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

CONMED has higher earnings, but lower revenue than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.76	$47.06M	$1.77	19.51
MiniMed Group	$2.99B	1.40	N/A	N/A	N/A

CONMED presently has a consensus target price of $43.80, suggesting a potential upside of 26.81%. MiniMed Group has a consensus target price of $21.33, suggesting a potential upside of 43.37%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, MiniMed Group had 5 more articles in the media than CONMED. MarketBeat recorded 9 mentions for MiniMed Group and 4 mentions for CONMED. CONMED's average media sentiment score of 0.20 beat MiniMed Group's score of -0.23 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

19.7% of MiniMed Group shares are held by institutional investors. 0.3% of CONMED shares are held by insiders. Comparatively, 2.2% of MiniMed Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CONMED has a net margin of 4.00% compared to MiniMed Group's net margin of 0.00%. CONMED's return on equity of 13.84% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
MiniMed Group	N/A	N/A	N/A

Summary

MiniMed Group beats CONMED on 8 of the 12 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNMD vs. The Competition

Export

Metric	CONMED	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$1.06B	$15.69B	$6.49B	$23.05B
Dividend Yield	N/A	1.16%	2.67%	4.10%
P/E Ratio	19.51	18.48	23.92	30.30
Price / Sales	0.76	2.30	507.57	22.44
Price / Cash	4.88	13.58	26.99	18.46
Price / Book	1.04	3.33	10.28	4.61
Net Income	$47.06M	$534.24M	$3.57B	$1.07B
7 Day Performance	-0.18%	2.80%	-1.43%	-1.80%
1 Month Performance	-6.29%	11.71%	3.27%	-1.21%
1 Year Performance	-39.34%	0.15%	23.37%	21.30%

CONMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
CNMD CONMED	4.0671 of 5 stars	$34.54 -1.8%	$43.80 +26.8%	-38.4%	$1.06B	$1.37B	19.51	3,900
MMSI Merit Medical Systems	4.7737 of 5 stars	$62.05 -1.6%	$92.80 +49.6%	-32.3%	$3.76B	$1.54B	26.86	7,500
LIVN LivaNova	2.6688 of 5 stars	$73.81 +0.0%	$79.38 +7.5%	+57.5%	$4.05B	$1.43B	37.85	3,300
NVST Envista	2.9142 of 5 stars	$23.34 -0.9%	$28.83 +23.5%	+22.9%	$3.80B	$2.81B	56.93	12,000
IRTC iRhythm Technologies	4.2914 of 5 stars	$109.17 -4.2%	$189.69 +73.8%	-26.3%	$3.74B	$787.85M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNMD) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONMED (CNMD) Competitors

CNMD vs. MMSI, LIVN, NVST, IRTC, and MMED

How does CONMED compare to Merit Medical Systems?

Summary

How does CONMED compare to LivaNova?

Summary

How does CONMED compare to Envista?

Summary

How does CONMED compare to iRhythm Technologies?

Summary

How does CONMED compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CONMED (CNMD) Competitors

CNMD vs. MMSI, LIVN, NVST, IRTC, and MMED

How does CONMED compare to Merit Medical Systems?

Do analysts prefer CNMD or MMSI?

Do institutionals and insiders hold more shares of CNMD or MMSI?

Which has preferable earnings & valuation, CNMD or MMSI?

Is CNMD or MMSI more profitable?

Does the media refer more to CNMD or MMSI?

Which has more risk and volatility, CNMD or MMSI?

Summary

How does CONMED compare to LivaNova?

Do analysts recommend LIVN or CNMD?

Do institutionals & insiders have more ownership in LIVN or CNMD?

Does the media prefer LIVN or CNMD?

Is LIVN or CNMD more profitable?

Which has stronger earnings & valuation, LIVN or CNMD?

Which has more risk & volatility, LIVN or CNMD?

Summary

How does CONMED compare to Envista?

Is CNMD or NVST more profitable?

Which has higher valuation and earnings, CNMD or NVST?

Which has more risk & volatility, CNMD or NVST?

Do analysts prefer CNMD or NVST?

Does the media prefer CNMD or NVST?

Summary

How does CONMED compare to iRhythm Technologies?

Does the media favor IRTC or CNMD?

Is IRTC or CNMD more profitable?

Which has better earnings and valuation, IRTC or CNMD?

Which has more volatility & risk, IRTC or CNMD?

Do analysts rate IRTC or CNMD?

Summary

How does CONMED compare to MiniMed Group?

Which has preferable valuation & earnings, CNMD or MMED?

Do analysts prefer CNMD or MMED?

Does the media prefer CNMD or MMED?

Do institutionals and insiders believe in CNMD or MMED?

Is CNMD or MMED more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools